Skip to content
MarketScale
‹ Back to IndustriesHealthcare

CurveBeam Relocates Headquarters for Expanding Team

In 2009, a group of professionals with a passion and proficiency in extremity CT imaging joined together and formed CurveBeam. Since then, the entirely employee-owned company has built strong relationships within the orthopedic & radiology communities and uses the knowledge from those connections to continually improve its Cone Beam CT imaging equipment. After nearly decade of…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

In 2009, a group of professionals with a passion and proficiency in extremity CT imaging joined together and formed CurveBeam. Since then, the entirely employee-owned company has built strong relationships within the orthopedic & radiology communities and uses the knowledge from those connections to continually improve its Cone Beam CT imaging equipment. After nearly decade of growth, it does not appear that CurveBeam will slow down anytime soon.

Relocation to Hatfield

In addition to rolling out a new logo and website, CurveBeam recently relocated its headquarters. The new corporate office is located in Hatfield, just outside of Philadelphia, Pennsylvania. The new facility is roughly twice the size of CurveBeam’s previous home, giving the company plenty of “room to continue growing in terms of both people and inventory,” according to Marketing Manager Vinti Singh. The move will also accommodate all upcoming R & D projects.

Today, Cone Beam CT scans are a highly regarded option in imaging, and CurveBeam is setting new standards in orthopedic 3D imaging worldwide. CurveBeam is proud of its commitment to local and American parts and materials, as well as innovation and integrity in imaging technology.

Watch a video about CurveBeam here.

Read more at curvebeam.com

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Leading with Purpose: Dr. David Foster on Faith, Healthcare Leadership, and Physician Collaboration

Dr. David Foster discusses the importance of faith in healthcare leadership and the role of physician collaboration. The conversation emphasizes how values-driven leadership can positively impact patient care. The dialogue also explores the significance of integrating personal beliefs in professional settings.

  • 01Values-driven leadership can significantly enhance patient care.
  • 02Integrating personal beliefs in professional settings can benefit healthcare leadership.
  • 03Collaboration among physicians is crucial for effective healthcare leadership.

Aug 4, 2026

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health venture funding reached $7.4B in the first half of 2026, with significant investments in AI agent platforms and chronic care tools. Mega-deals of over $100 million were a key driver of the funding surge.

  • 01Digital health VC funding hit $7.4 billion in the first half of 2026.
  • 02Mega-deals in AI agent platforms and chronic care tools exceeded $100 million.
  • 03AI, chronic care, and workforce tools dominate digital health investments.

Aug 4, 2026

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512